FDA Issues Approval For Bayer Autoinjector For Multiple Sclerosis Therapy The FDA has approved Bayer’s autoinjector BETACONNECT as a means of administrating BETASERON for treating relapsing-remitting multiple sclerosis, offering another treatment option for the disease. by Dianne Depra